<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: HIV enters the brain soon after <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> causing neuronal damage and microglial/astrocyte dysfunction leading to neuropsychological impairment </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the impact of HIV on resting cerebral blood flow (rCBF) within the lenticular nuclei (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) and visual cortex (VC) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This cross-sectional study used arterial spin labeling MRI (ASL-MRI) to measure rCBF within 33 HIV+ and 26 HIV- subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Nonparametric Wilcoxon rank sum test assessed rCBF differences due to HIV serostatus </plain></SENT>
<SENT sid="4" pm="."><plain>Classification and regression tree (CART) analysis determined optimal rCBF cutoffs for differentiating HIV serostatus </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of neuropsychological impairment and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> duration on rCBF were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: rCBF within the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> and VC were significantly reduced for HIV+ compared to HIV- subjects </plain></SENT>
<SENT sid="7" pm="."><plain>A 2-tiered CART approach using either <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> rCBF &lt; or =50.09 mL/100 mL/min or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> rCBF &gt;50.09 mL/100 mL/min but VC rCBF &lt; or =37.05 mL/100 mL/min yielded an 88% (29/33) sensitivity and an 88% (23/26) specificity for differentiating by HIV serostatus </plain></SENT>
<SENT sid="8" pm="."><plain>HIV+ subjects, including neuropsychologically unimpaired, had reduced rCBF within the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> (p = 0.02) and VC (p = 0.001) compared to HIV- controls </plain></SENT>
<SENT sid="9" pm="."><plain>A temporal progression of brain involvement occurred with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> rCBF significantly reduced for both <z:hpo ids='HP_0011009'>acute</z:hpo>/early (&lt;1 year of seroconversion) and <z:hpo ids='HP_0011010'>chronic</z:hpo> HIV-infected subjects, whereas rCBF in the VC was diminished for only <z:hpo ids='HP_0011010'>chronic</z:hpo> HIV-infected subjects </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Resting cerebral blood flow (rCBF) using arterial spin labeling MRI has the potential to be a noninvasive neuroimaging biomarker for assessing HIV in the brain </plain></SENT>
<SENT sid="11" pm="."><plain>rCBF reductions that occur soon after seroconversion possibly reflect neuronal or vascular injury among HIV+ individuals not yet expressing neuropsychological impairment </plain></SENT>
</text></document>